Gene · 2358
Papers3,281
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,281
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Anti-inflammatory Annexin A1 in Periodontitis via Formyl Peptide Receptor 2. | J Dent Res | 2025 | 40108522 | PubTator, text mining | PubMed |
| Formyl peptide receptor 2: a potential therapeutic target for inflammation-related diseases. | Pharmacol Rep | 2025 | 40102363 | PubTator, text mining | PubMed |
| Metabolic signaling of ceramides through the FPR2 receptor inhibits adipocyte thermogenesis. | Science | 2025 | 40080544 | Swiss-Prot, curated | PubMed |
| Functional Interactions Between Recombinant Serum Amyloid A1 (SAA1) and Chemokines in Leukocyte Recruitment. | Int J Mol Sci | 2025 | 40076881 | PubTator, text mining | PubMed |
| Oral FPR2/ALX modulators tune myeloid cell activity to ameliorate mucosal inflammation in inflammatory bowel disease. | Acta Pharmacol Sin | 2025 | 40069490 | PubTator, text mining | PubMed |
| Resolvin D1 suppresses inflammation in human fibroblast-like synoviocytes via the p-38, NF-κB, and AKT signaling pathways. | In Vitro Cell Dev Biol Anim | 2025 | 40064746 | PubTator, text mining | PubMed |
| Role of Formyl Peptide Receptor 2 and Toll-Like Receptor 2 in Skin Barrier Function and Atopic Dermatitis. | J Invest Dermatol | 2025 | 40057860 | PubTator, text mining | PubMed |
| Potential Crosstalk Between ANXA1+ Epithelial Cells and FABP4+ TAM Cells of Ferroptosis-Related Molecular Clusters Promotes an Immunosuppressive Microenvironment in Non-Small Cell Lung Cancer. | Mol Carcinog | 2025 | 40040274 | PubTator, text mining | PubMed |
| Iron-lead mixed exposure causes bone damage in mice: A multi-omics analysis. | Ecotoxicol Environ Saf | 2025 | 40037083 | PubTator, text mining | PubMed |
| Discovery of Endothelial-Monocyte Crosstalk in Ischemic-Reperfusion Injury Following Liver Transplantation Based on Integration of Single-Cell RNA and Transcriptome RNA Sequencing. | J Cell Mol Med | 2025 | 39993960 | PubTator, text mining | PubMed |
| Aspirin-triggered RvD1 (AT-RvD1) modulates epithelial-mesenchymal transition on bronchial epithelial cells stimulated with cigarette smoke extract. | Prostaglandins Other Lipid Mediat | 2025 | 39984154 | PubTator, text mining | PubMed |
| Novel Carbocyclic Phenylpyrrolidinone Urea Compounds as FPR2 Agonists for Treating Atherosclerosis and Heart Failure. | ACS Med Chem Lett | 2025 | 39967624 | PubTator, text mining | PubMed |
| Cycloastragenol targets Fpr2 to inhibit the TLR4/NF-κB signaling pathway and alleviate neuroinflammation in Parkinson's disease. | Phytomedicine | 2025 | 39922145 | PubTator, text mining | PubMed |
| SEED-Selection enables high-efficiency enrichment of primary T cells edited at multiple loci. | Nat Biotechnol | 2025 | 39910194 | PubTator, text mining | PubMed |
| Comprehensive analysis of heterogeneity and cell-cell interactions in Crohn's disease reveals novel location-specific insights. | J Adv Res | 2025 | 39732334 | PubTator, text mining | PubMed |
| GRK5 regulates endocytosis of FPR2 independent of β-arrestins. | J Biol Chem | 2025 | 39706266 | PubTator, text mining | PubMed |
| Combined Bulk and Single-Cell Transcriptomic Analysis to Reveal the Potential Influences of Intestinal Inflammatory Disease on Multiple Sclerosis. | Inflammation | 2025 | 39680254 | PubTator, text mining | PubMed |
| Inflammaging and Immunosenescence in the Post-COVID Era: Small Molecules, Big Challenges. | ChemMedChem | 2025 | 39651728 | PubTator, text mining | PubMed |
| Pro-resolving lipid mediators and therapeutic innovations in resolution of inflammation. | Pharmacol Ther | 2025 | 39566561 | PubTator, text mining | PubMed |
| Apocrine Gland Damage and the Release of Specific Keratins in Early Stage Indicate the Crucial Involvement of Apocrine Glands in Hidradenitis Suppurativa. | J Invest Dermatol | 2025 | 39547394 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2358/papers?page=7